基础医学与临床 ›› 2009, Vol. 29 ›› Issue (11): 1211-1214.

• 研究论文 • 上一篇    下一篇

nor-NOHA逆转自发性高血压大鼠血管重构

马玲 Demougeot C Bagnost T Berthelot A   

  1. 新疆医科大学公共卫生学院
  • 收稿日期:2008-11-20 修回日期:2009-06-15 出版日期:2009-11-20 发布日期:2009-11-20
  • 通讯作者: 马玲

Effect of arginase inhibitor on the vascular remodeling in SHR

Ling MA, C Demougeot, T Bagnost, A Berthelot   

  1. College of Public Health, Xinjiang Medical University
  • Received:2008-11-20 Revised:2009-06-15 Online:2009-11-20 Published:2009-11-20
  • Contact: Ling MA,

摘要: 目的 探讨精氨酸酶抑制剂nor-NOHA对自发性高血压大鼠(SHR)血管重构的影响。方法WKY大鼠作为对照组,SHR随机分为模型组与受试组,受试组每天腹腔注射nor-NOHA(40 mg/kg),定期测量大鼠收缩压和体质量,10周后,采用酶谱法检测心、肾及胸主动脉组织中活性MMP-2的含量,并对胸主动脉进行Tricrome- Masson,Picric-Sirius red 及Orcein组织特染观察中膜厚度(MT)、管腔内径(LD)、径腔比(M/L)、Ⅰ型和Ⅲ型胶原及弹力纤维面积百分比值等。 结果 受试组收缩压显著下降、左心室MMP-2较SHR组含量显著降低(P<0.05),胸主动脉的MT、M/L、Ⅰ型和Ⅲ型胶原蛋白均下降(P<0.05)。结论 nor-NOHA可能通过抑制MMP-2活性及降低Ⅰ型和Ⅲ型胶原的合成而缓解SHR血管重构。

关键词: SHR, 血管重构, 精氨酸酶抑制剂, MMP-2, nor-NOHA

Abstract: Objective To determine the role of arginase inhibitor (nor-NOHA) on vascular remodeling in SHRs。Methods WKY rats were used as the control and SHR were randomly divided into untreated control(SHR) and treated group(SHR-T). SHR in the treated groups were injected intraperitoneally every day with nor-NOHA(40 mg/kg )for 10 weeks while the control groups were given to saline. Indirect tail-cuff systolic blood pressures and body weight were measured at given times. After the experiment ,The thoracic aorta、left ventricular(LV) and left kidney were taken . The contents of activated MMP-2 in these organs were measured by semi-quantitative gelatine-zymography,meanwhile Media thickness(MT), luminal diameter(LD), ratio of media to lumen (M/L) and collagen type I and Ⅲ, elastic fibers of thoracic aorta were measured by special Tricrome Masson, Picric-Sirius red and Orcein staining methods. Results (1) Blood pressure of treated group was significantly lower than untreated control groups;(2) Much more MMP-2 in LV exsited in SHR group than in SHR-T group .(3)MT and M/L of treated group were significantly smaller than untreated control groups in thoracic aorta; Much more collagen I and III existing in the vascular of untreated control group compare with treated group.;Conclusions nor-NOHA could relieve vascular remodeling probably by inhibiting the activity of MMP-2 and the synthesis of collagen I and III.

Key words: SHR, Vascular remodeling, Arginase inhibitor, MMP-2